This federal contract award, with an ID of SPE2DB20D1047|SPE2DB25FF31K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,627.41 firm-fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 9, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs medical systems.
Generated 3/7/25, 10:13 AM